RWE Study Shows: New Diabetes Medications Were Actively Adopted Between 2012–2019 – The Results Are Promising
The adoption of new diabetes medications in Finland was active between 2012 and 2019, according to an RWE (Real World Evidence) study published in May 2024. The study was conducted by Medaffcon in collaboration with the pharmaceutical company Sanofi.